Epizyme (NASDAQ:EPZM)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar chris293 (83.99) Submitted: 10/8/2013 5:09:14 PM : Underperform Start Price: $37.89 EPZM Score: +44.54

A fast check of the financial reports as of 7/13 seems to say increased costs and increased by quite a bit income loss depend on meeting targets set by other medical drug companies do not bode well for now. Wait and see.

Featured Broker Partners


Advertisement